cyclofenil (C09-0800-522)

Catalog No.: C09-0800-522
Mfr. No.: C133771-5g
Mfr. Name: Aladdin Scientific
Qty/UOM: 1
UOM: EA

Price: $836.64

List Price: $929.59

Cyclofenil is a non-steroidal selective estrogen receptor modulator (SERM). Cyclofenil shows a higher affinity for ERβ than ERα.A selective estrogen receptor modulator.

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

Cyclofenil is a non-steroidal selective estrogen receptor modulator (SERM). Cyclofenil shows a higher affinity for ERβ than ERα.A selective estrogen receptor modulator. Specification: ≥98% Molecular Formula: C23H24O4 Molecular Weight: 364.434 PubChem CID: 2898 Isomeric SMILES: CC(=O)OC1=CC=C(C=C1)C(=C2CCCCC2)C3=CC=C(C=C3)OC(=O)C Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/C133771-SCI_81db4adfe82e230a80687b51b194dc5a.pdf

UPC:: 51181920
Condition:: New
Availability:: 2 weeks
Weight:: 2.85 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: C133771-5g
CAS:: 2624-43-3
Product Size:: 5g
Hazard Statement Codes:: H315:H319:H361
Precautionary Statement Codes:: P264:P280:P302+P352:P305+P351+P338:P362+P364:P405:P501

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."